Alteration in composition of keratin intermediate filaments in a model of breast cancer progression and the potential to reverse hallmarks of metastasis

Cancer Biomarkers

Volumn 12, Issue 2, 2012, Pages 49-64

  MacKinder, Mary Anne ^a   Evans, Caroline Akrill ^a   Chowdry, Joanna ^a   Staton, Carolyn Ann ^a   Corfe, Bernard Michael ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

breast cancer; Epithelial mesenchymal transition; intermediate filaments; keratins

Indexed keywords

CYTOKERATIN 18; CYTOKERATIN 19; CYTOKERATIN 8; INTERMEDIATE FILAMENT PROTEIN; SHORT HAIRPIN RNA; SMALL INTERFERING RNA; TRIFLUOROACETIC ACID; VASCULOTROPIN; VIMENTIN;

ARTICLE; ATYPICAL DUCTAL HYPERPLASIA; BREAST ADENOCARCINOMA; BREAST CANCER; BREAST CARCINOMA; BREAST METASTASIS; CANCER GROWTH; CANCER INHIBITION; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; INTERMEDIATE FILAMENT; INTRADUCTAL CARCINOMA; METASTASIS POTENTIAL; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN CONTENT; WESTERN BLOTTING;

BREAST NEOPLASMS; CELL LINE, TUMOR; DISEASE PROGRESSION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENTS; KERATINS; NEOPLASM METASTASIS;

EID: 84874293160     PISSN: 15740153     EISSN: 18758592     Source Type: Journal    
DOI: 10.3233/CBM-120293     Document Type: Article

References (32)

1. F. Kamangar, G.M. Dores and W.F. Anderson, Patterns of cancer incidence, mortality, and prevalence across five continents: Defining priorities to reduce cancer disparities in different geographic regions of the world, J Clin Oncol 24 (2006), 2137-2150. (Pubitemid 46655601)
2. M.J.C. Hendrix, E.A. Seftor, Y.W. Chu, K.T. Trevor and R.E.B. Seftor, Role of intermediate filaments in migration, invasion and metastasis, Cancer Metastasis Rev 15 (1996), 507- 525. (Pubitemid 27067169)
3. B. Willipinski-Stapelfeldt, S. Riethdorf, V. Assmann, U. Woelfle, T. Rau, G. Sauter, J. Heukeshoven and K. Pantel, Changes in cytoskeletal protein composition indicative of an epithelial-mesenchymal transition in human micrometastatic and primary breast carcinoma cells, Clin Cancer Res 11 (2005), 8006-8014. (Pubitemid 41698741)
4. P.M. Steinert, A.C.T. North and D.A.D. Parry, Structural Features of Keratin Intermediate Filaments, J Invest Dermatol 103 (1994), S19-S24.
5. L. Galarneau, A. Loranger, S. Gilbert and N. Marceau, Keratins modulate hepatic cell adhesion, size and G1/S transition, Experimental Cell Research 313 (2007), 179-194. (Pubitemid 44958462)
6. N. Obermajer, B. Doljak and J. Kos, Cytokeratin 8 ectoplasmic domain binds urokinase-type plasminogen activator to breast tumor cells and modulates their adhesion, growth and invasiveness, Molecular Cancer 8 (2009), Article No. 88.
7. R. Moll, W.W. Franke, D.L. Schiller, B. Geiger and R. Krepler, The Catalogue of Human Cytokeratins - Patterns of Expression in Normal Epithelia, Tumors and Cultured-Cells, Cell 31 (1982), 11-24. (Pubitemid 13215192)
8. J. Taylorpapadimitriou, M. Stampfer, J. Bartek, A. Lewis, M. Boshell, E.B. Lane and I.M. Leigh, Keratin Expression in Human Mammary Epithelial-Cells Cultured from Normal and Malignant-Tissue - Relation to Invivo Phenotypes and Influence of Medium, J Cell Sci 94 (1989), 403.
9. B. Boyer, A.M. Valles and N. Edme, Induction and regulation of epithelial-mesenchymal transitions, Biochem Pharmacol 60 (2000), 1091-1099.
10. J.P. Thiery, Epithelial-mesenchymal transitions in tumour progression, Nat Rev Cancer 2 (2002), 442-454.
11. C. Gilles, M. Polette, J.M. Zahm, J.M. Tournier, L. Volders, J.M. Foidart and P. Birembaut, Vimentin contributes to humanmammary epithelial cell migration, J Cell Sci 112 (1999), 4615-4625. (Pubitemid 30034810)
12. C.A. Livasy, G. Karaca, R. Nanda, M.S. Tretiakova, O.I. Olopade, D.T. Moore and C.M. Perou, Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma, Mod Pathol 19 (2006), 264-271. (Pubitemid 43117611)
13. R.R. Parikh, Q.F. Yang, S.A. Higgins and B.G. Haffty, Outcomes in young women with breast cancer of triple-negative phenotype: The prognostic significance of CK19 expression, Int J Radiat Oncol Biol Phys 70 (2008), 35-42. (Pubitemid 350251027)
14. G. Schaller, I. Fuchs, W. Pritze, A. Ebert, H. Herbst, K. Pantel, H. Weitzel and E. Lengyel, Elevated keratin 18 protein expression indicates a favourable prognosis in patients with breast cancer, Clin Cancer Res 2 (1996), 1879-1885. (Pubitemid 26384156)
15. D.A. Zajchowski, M.F. Bartholdi, Y. Gong, L. Webster, H.L. Liu, A. Munishkin, C. Beauheim, S. Harvey, S.P. Ethier and P.H. Johnson, Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells, Cancer Res 61 (2001), 5168-5178. (Pubitemid 32681550)
16. V. Barak, H. Goike, K.W. Panaretakis and R. Einarsson, Clinical utility of cytokeratins as tumor markers, Clinical Biochemistry 37 (2004), 529-540. (Pubitemid 38845016)
17. N.O. Ku, S. Azhar and M.B. Omary, Keratin 8 phosphorylation by p38 kinase regulates cellular keratin filament reorganization - Modulation by a keratin 1-like disease-causing mutation, J Biol Chem 277 (2002), 10775-10782. (Pubitemid 34952830)
18. N.O. Ku and M.B. Omary, Keratins turn over by ubiquitination in a phosphorylation-modulated fashion, Journal of Cell Biology 149 (2000), 547-552. (Pubitemid 30252389)
19. C. Choudhary, C. Kumar, F. Gnad, M.L. Nielsen, M. Rehman, T.C. Walther, J.V. Olsen and M. Mann, Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions, Science 325 (2009), 834-840.
20. S.H. Leech, C.A. Evans, L. Shaw, C.H. Wong, J. Connolly, J.R. Griffiths, A.D.Whetton and B.M. Corfe, Proteomic analyses of intermediate filaments reveals cytokeratin8 is highly acetylated - implications for colorectal epithelial homeostasis, Proteomics 8 (2008), 279-288. (Pubitemid 351212327)
21. H. Herrmann, L. Kreplak and U. Aebi, Isolation, characterization, and in vitro assembly of intermediate filaments, Intermediate Filament Cytoskeleton 78 (2004), 3-24.
22. J.R. Griffiths, R.D. Unwin, C.A. Evans, S.H. Leech, B.M. Corfe and A.D.Whetton, The application of hypothesis driven strategy to the sensitive detection and location of acetylated lysine residues, J of the American Soc for Mass Spectrometry 18(8) (2007), 1423-1428. (Pubitemid 47088996)
23. J.E. Bluff, M. Amarzguioui, J. Slattery, N.J. Brown, M.W.R. Reed and C.A. Staton, Anti-tissue factor short hairpin RNA inhibits breast cancer growth in vivo, Breast Cancer Research and Treatment 128 (2011), 691-701.
24. U.Woelfle, G. Sauter, S. Santjer, R. Brakenhoff and K. Pantel, Down-regulated expression of cytokeratin 18 promotes progression of human breast cancer, Clin Cancer Res 10 (2004), 2670-2674. (Pubitemid 38509140)
25. R. Moll, Cytokeratins as markers of differentiation. Expression profiles in epithelia and epithelial tumors, Veroff Pathol 142 (1993), 1-197.
26. L. McInroy and A. Maatta, Down-regulation of vimentin expression inhibits carcinoma cell migration and adhesion, Biochem Biophys Res Commun 360 (2007), 109-114. (Pubitemid 46990330)
27. R.J. Paccione, H. Miyazaki, V. Patel, A. Waseern, J.S. Gutkind, Z.E. Zehner and W.A. Yeudall, Keratin downregulation in vimentin-positive cancer cells is reversible by vimentin RNA interference, which inhibits growth and motility, Molecular Cancer Therapeutics 7 (2008), 2894-2903.
28. C.L. Sommers, S.E. Heckford, J.M. Skerker, P. Worland, J.A.Torri, E.W. Thompson, S.W. Byers and E.P. Gelmann, Loss of Epithelial Markers and Acquisition of Vimentin Expression in Adriamycin-Resistant and Vinblastine-Resistant Human Breast-Cancer Cell-Lines, Cancer Res 52 (1992), 5190-5197.
29. D.K. Trask, V. Band, D.A. Zajchowski, P. Yaswen, T. Suh and R. Sager, Keratins as Markers That Distinguish Normal and Tumor-Derived Mammary Epithelial-Cells, Proc Natl Acad Sci USA 87 (1990), 2319-2323.
30. P.J.M. Drake, G.J. Griffiths, L. Shaw, R.P. Benson and B.M. Corfe, Application of High-Content Analysis to the Study of Post-Translational Modifications of the Cytoskeleton, J Proteome Res 8 (2009), 28-34.
31. J.E. Bluff, S.R. Menakuru, S.S. Cross, S.E. Higham, S.P. Balasubramanian, N.J. Brown, M.W. Reed and C.A. Staton, In human breast cancer the angiogenic switch occurs at the onset of dysplasia in the breast, British Journal of Cancer 18 (2009), 666-672.
32. T. Ueno, M. Toi, M. Koike, S. Nakamura and T. Tominaga, Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration, British Journal of Cancer Care 83 (2000), 164-170. (Pubitemid 30411712)